An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigenMiladys Limonta‐Fernández, Gerardo Guillén, Gilda Lemos et al.|New Biotechnology|2022Cited by 58
A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in miceLaura Lazo, Gerardo Guillén, Mónica Béquet‐Romero et al.|Vaccine|2022Cited by 21
The SARS-CoV-2 receptor-binding domain expressed in Pichia pastoris as a candidate vaccine antigenMiladys Limonta‐Fernández, Gerardo Guillén, Glay Chinea-Santiago et al.|medRxiv|2021Cited by 19
Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteersAnia Cabrales, Luis Javier González, Jeovanis Gil et al.|European Journal of Pharmaceutical Sciences|2012Cited by 15
Addition of nucleotide adjuvants enhances the immunogenicity of a recombinant subunit vaccine against the Zika virus in BALB/c miceIris Valdés, Gerardo Guillén, Edith Suzarte et al.|Vaccine|2024Cited by 5